News this week from BIA, Tolera and Alexar – People on the move
in-PharmaTechnologist.com presents its weekly round-up of the new faces and changing places in the pharma biz, including news this week from BIA, Tolera and Alexar.
in-PharmaTechnologist.com presents its weekly round-up of the new faces and changing places in the pharma biz, including news this week from BIA, Tolera and Alexar.
Swedish CMO Recipharm has won a development and manufacturing deal with Astimex Pharma and may be in the running for future contracts.
Novasep plans to build the ‘world’s largest’ chromatography-based API production plant with backing the French government, banks and gas firm Total.
A new independent review panel will decide to grant access to GSK’s clinical trial data based on scientific merit.
Albemarle says it is seeing a flight to quality as pharmaceutical fine chemical customers begin to return to western suppliers.
Demand for better bioavailability drove another deal this week with Bend Research and Dow teaming up to develop spray drying-based solutions.